Cidara Therapeutics, Inc.(CDTX)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

CDTX iron condor setups CDTX expected move CDTX IV rank history CDTX Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

CDTX $221.40 —
Snapshot
$221.40
52-Week Range
$54.52 – $221.42
YTD
+0.17%
IV Rank (30D)
33.89
Straddle Price
$1.70
P/C Vol Ratio
0.08
Market Cap
$7.0B
Info
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS
Market Cap
$7.0B

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 4112 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $220.58
SMA 50: $185.09
SMA 200: $83.68
Current: $221.38
EMA 12: $220.54
EMA 26: $212.51
MACD: 8.0256 | Signal: -2.9327
BULLISH
ADX (14): 73.39
STRONG TREND
+DI: 53.69
−DI: 8.55
Momentum Oscillators
RSI (14): 84.21
OVERBOUGHT
Stoch %K: 95.29
Stoch %D: 92.49
Williams %R: -2.65
Volume & Volatility
BB Upper: $221.47
BB Lower: $219.69
NEUTRAL
OBV: 73,352,740
Vol SMA 20: 1,046,711
Vol ROC: 42.98%
ATR: $1.62
True Range: $0.16
HV 20: 2.4%
HV 30: 2.9%
HV 60: 152.0%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-01-09T00:00:00 – 2026-01-06T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
5 of 5 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-13 After-Close 61.93% 5.84% 0.09x Within
2024-11-07 After-Close 53.84% 3.16% 0.06x Within
2025-05-08 After-Close 28.38% 3.43% 0.12x Within
2025-08-07 After-Close 11.43% 2.34% 0.20x Within
2025-11-06 After-Close 14.70% 4.54% 0.31x Within
Options Activity
IV Rank (30D)
33.89
IV Rank (7D)
22.34
Avg IV
102.7%
Straddle (30D)
$1.70
Straddle (7D)
$1.68
P/C Volume
0.08
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Insufficient price history — listed 4112 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.
Institutional Ownership (13F)
Latest filings — 2025-12-31
Diluted shares outstanding: 15,739,285 (as of 2025-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

11 filers2,807,249 shares$611.94M value17.84% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 2,007,193 $443.37M 72.45% 12.75% 2025-12-31
2 MORGAN STANLEY Custodian 542,722 $119.88M 19.59% 3.45% 2025-12-31
3 KRYGER CAPITAL Ltd 185,313 $40.93M 6.69% 1.18% 2025-12-31
4 AXA Investment Managers S.A. 61,154 $5.86M 0.96% 0.39% 2025-09-30
5 Transmarket Holdings LP 5,360 $1.18M 0.19% 0.03% 2025-12-31
6 Bryce Point Capital, LLC 3,977 $380.84K 0.06% 0.03% 2025-09-30
7 CIBC WORLD MARKETS CORP 1,297 $286.49K 0.05% <0.01% 2025-12-31
8 Global Retirement Partners, LLC 205 $45.28K <0.01% <0.01% 2025-12-31
9 COMERICA BANK Custodian 12 $2.56K <0.01% <0.01% 2025-12-31
10 SageView Advisory Group, LLC 9 $1.99K <0.01% <0.01% 2025-12-31
11 CIBC Private Wealth Group LLC 7 $1.55K <0.01% 0.00% 2025-12-31
1 filers$883.56K notional
# Filer Notional Value % of Total Period
1 DV EQUITIES, LLC $883.56K 100.00% 2025-12-31
1 filers$375.51K notional
# Filer Notional Value % of Total Period
1 DV EQUITIES, LLC $375.51K 100.00% 2025-12-31
Insider Activity
Latest: 2026-01-07
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-01-07 James Merson Director Disp (D) −17,475 opt — EDGAR
2026-01-07 Ryan Spencer Director Disp (D) −17,475 opt — EDGAR
2026-01-07 Joshua Resnick Director Disp (D) −27,279 opt — EDGAR
2026-01-07 Shane Ward COO & CLO Disp (D) −25,083 $221.50 -$5.56M EDGAR
2026-01-07 Bonnie L Bassler Director Disp (D) −15 $221.50 -$3.3K EDGAR
2026-01-07 FRANK KARBE Chief Financial Officer Disp (D) −50,651 $221.50 -$1.67M EDGAR
2026-01-07 Jeffrey Stein President & CEO Disp (D) −75,640 $221.50 -$16.75M EDGAR
2026-01-07 Carin Canale-Theakston Director Disp (D) −35,375 opt — EDGAR
2026-01-07 Chrysa Mineo Director Disp (D) −3,320 $221.50 -$735.4K EDGAR
2026-01-07 Theodore R Schroeder Director Disp (D) −41,100 opt — EDGAR
2026-01-07 Jeffrey Stein President & CEO Mixed −1,864 $79.55 — EDGAR
2026-01-07 DANIEL D BURGESS Director Disp (D) −150 $221.50 -$33.2K EDGAR
2026-01-07 Nicole Negar Davarpanah Chief Medical Officer Disp (D) −20,886 $221.50 -$2.78M EDGAR
2025-12-29 Nicole Negar Davarpanah Chief Medical Officer Gift (G) −450 — EDGAR
2025-12-29 Jeffrey Stein President & CEO Gift (G) −5,425 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
24 insiders · @ $221.38
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Rajeev M. Shah Director 3,365,523 $745.06M $400.00M 2 2025-06-30
2 RA Capital Healthcare Fund LP Director 1,092,796 $241.92M $0 3 2025-01-07
3 Peter Kolchinsky Director 703,080 $155.65M $0 2 2024-07-22
4 BB BIOTECH AG 10%+ Owner 114,764 $25.41M $907.9K 1 2017-11-16
5 5AM Co-Investors III, L.P. 10%+ Owner 97,805 $21.65M $0 1 2015-04-22
6 Nina S Kjellson Director 67,841 $15.02M $3.20M 1 2015-04-22
7 FRANK KARBE Chief Financial Officer 43,125 $9.55M $0 3 2026-01-07
8 STEVE ELMS Director 35,155 $7.78M $0 1 2015-04-22
9 Taylor Sandison Chief Medical Officer 23,067 $5.11M $51.9K 23 2024-10-02
10 Preetam Shah Chief Financial Officer 16,798 $3.72M -$4.1K 9 2024-10-02
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

TTM Net Income$-0.2B
TTM EPS$-10.63